Journal profile
Cambridge Prisms Precision Medicine
ISSN 2752-6143 · Cambridge University Press · United Kingdom
Cambridge Prisms Precision Medicine: fully open access; APC about USD 3,893; review about 14 weeks (community reports); 62 articles in 2025; the journal's website says it has ceased publication.
The journal's website says it has ceased publication: Cambridge Prisms: Precision Medicine will have ceased publication at the end of 2025, and new submissions to the journal are no longer being accepted. All published materials will remain available through the Cambridge University Press platform in perpetuity. Source ↗Publisher website ·
Scope
Aims, scope and focus
Cambridge Prisms Precision Medicine is published by Cambridge University Press. By OpenAlex counts of its recent articles, its largest topics are Genetic Associations and Epidemiology, Artificial Intelligence in Healthcare and Education and Genomics and Rare Diseases, together about 33.3% of its articles. Its main subfields are Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Cambridge Prisms: Precision Medicine will have ceased publication at the end of 2025, and new submissions to the journal are no longer being accepted. All published materials will remain available through the Cambridge University Press platform in perpetuity.Cambridge Prisms: Precision Medicine is an approach to maximise the effectiveness of disease treatment and prevention by taking into account variability in genes, environment and lifestyle. It seeks to redefine our understanding of disease onset and progression, treatment response, and health outcomes through the more precise measurement of molecular, environmental, and behavioural factors that contribute to health and disease. This understanding can lead to diagnoses that are more accurate, to disease prevention strategies that are more rational, to a better treatment selection, and to the development of novel therapies.
From the journal's Aims & Scope
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology15.6%
- Artificial Intelligence in Healthcare and EducationMedicine9.8%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology7.9%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics7.2%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology6.7%
- Race, Genetics, and SocietyBiochemistry, Genetics and Molecular Biology5.6%
- Cancer Immunotherapy and BiomarkersMedicine4.1%
- Nutrition, Genetics, and DiseaseBiochemistry, Genetics and Molecular Biology3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 17OpenAlex ·
- i10-index
- 31OpenAlex ·
- 2-year mean citedness
- 7.77OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 435 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 208 |
| 2025 | 62 | 61 | 176 |
| 2024 | 50 | 46 | 126 |
| 2023 | 184 | 181 | 141 |
| 2022 | 139 | 131 | 70 |
| 2021 | 0 | 0 | 1 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 7 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 14 weeksLetPub ·
- Peer review
- Open peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,893 / GBP 2,968 | — | — | |
| LetPub | USD 3,780 / GBP 2,800 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- case studiesCase studies*Length not stated
- case studyOverview Review*Review* (standard review)Research article*PerspectiveComment** (invited only)Case studies*Rapid Communication*Length not stated
- commentComment** (invited only)Length not stated
- overviewWe accept the following types of articles: OverviewLength not stated
- perspectivePerspectiveLength not stated
- rapid communicationOverview Review*Review* (standard review)Research article*PerspectiveComment** (invited only)Case studies*Rapid Communication*Length not stated
- research articleOverview Review*Review* (standard review)Research article*PerspectiveComment** (invited only)Case studies*Rapid Communication*Length not stated
- reviewOverview Review*Review* (standard review)Research article*PerspectiveComment** (invited only)Case studies*Rapid Communication*Length not stated
Policy excerpts from the journal's websitePeer review
- Peer review
Ceased publication at end of 2025; no new submissions; content remains available in perpetuity. Model summary
Cambridge Prisms: Precision Medicine will have ceased publication at the end of 2025, and new submissions to the journal are no longer being accepted. All published materials will remain available through the Cambridge University Press platform in perpetuity.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Cambridge University Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2752-6143
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Cambridge Prisms Precision Medicine
How long does peer review take at Cambridge Prisms Precision Medicine?
Authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Cambridge Prisms Precision Medicine open access, and what is the APC?
Cambridge Prisms Precision Medicine is a fully open-access journal. APC about USD 3,893.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .